Anti-RBD IgG dynamics following infection or vaccination

Amira Harrache,Kahina Saker,Bouchra Mokdad,Laurence Generenaz,Carla Saade,Sylvie Pons,Jean-Baptiste Fassier,COVID-SER Study group,Antonin Bal,Mary-Anne Trabaud,Muriel Rabilloud,Amna Abichou-Klich,Sophie Trouillet-Assant
DOI: https://doi.org/10.1016/j.vaccine.2024.126464
IF: 4.169
2024-10-20
Vaccine
Abstract:Identifying parameters influencing SARS-CoV-2 antibody dynamics post infection or vaccination is crucial for refining vaccination strategies. In a longitudinal analysis of 1340 samples from 375 healthcare workers, we characterized peak serological response and IgG half-life. Peak antibody titers post 2 vaccine doses were ∼ 20 times higher than natural infection; conversely, infected individuals had extended antibody half-life. Clinical and demographical factors such as BMI, age and smoking shaped peak response without affecting anti-RBD IgG half-life. A third mRNA vaccine dose increased peak antibody titers and prolonged half-life compared to the second dose. These findings underscore the diverse kinetics of SARS-CoV-2 antibody responses, which is influenced by immunization type/number and clinical factors.
What problem does this paper attempt to address?